1. Home
  2. FCRS vs VSTM Comparison

FCRS vs VSTM Comparison

Compare FCRS & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FCRS

FutureCrest Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.27

Market Cap

366.2M

Sector

Finance

ML Signal

N/A

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$5.49

Market Cap

395.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCRS
VSTM
Founded
2025
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.2M
395.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
FCRS
VSTM
Price
$10.27
$5.49
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.50
AVG Volume (30 Days)
94.1K
3.2M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$30,914,000.00
Revenue This Year
N/A
$282.64
Revenue Next Year
N/A
$72.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
209.14
52 Week Low
$10.02
$3.43
52 Week High
$10.92
$11.25

Technical Indicators

Market Signals
Indicator
FCRS
VSTM
Relative Strength Index (RSI) 51.70 72.07
Support Level $10.19 $4.99
Resistance Level $10.31 $6.80
Average True Range (ATR) 0.04 0.41
MACD 0.00 0.21
Stochastic Oscillator 57.14 96.50

Price Performance

Historical Comparison
FCRS
VSTM

About FCRS FutureCrest Acquisition Corp. Class A Ordinary Shares

FutureCrest Acquisition Corp is a blank check company.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: